PlainRecalls
FDA Devices Moderate Class II Terminated

Gynecare Thermachoice III Uterine Balloon Therapy System Ethicon, Inc. The GYNECARE THERMACHOICE¿ III Uterine Balloon Therapy (UBT) System is a thermal balloon ablation device intended to ablate the endometrial lining of the uterus in pre-menopausal women with menorrhagia (excessive uterine bleeding) due to benign causes for whom childbearing is complete.

Reported: January 13, 2016 Initiated: December 3, 2015 #Z-0602-2016

Product Description

Gynecare Thermachoice III Uterine Balloon Therapy System Ethicon, Inc. The GYNECARE THERMACHOICE¿ III Uterine Balloon Therapy (UBT) System is a thermal balloon ablation device intended to ablate the endometrial lining of the uterus in pre-menopausal women with menorrhagia (excessive uterine bleeding) due to benign causes for whom childbearing is complete.

Reason for Recall

Stability data does not substantiate the labeled two-year shelf life of affected product.

Details

Recalling Firm
Ethicon, Inc.
Units Affected
96,124 units
Distribution
Worldwide Distribution: US (nationwide) including Puerto Rico and countries of: India, Belgium, Argentina, Mexico, Brazil, Canada, Colombia, Ecuador, Singapore, Aruba and Venezuela.
Location
Somerville, NJ

Frequently Asked Questions

What product was recalled?
Gynecare Thermachoice III Uterine Balloon Therapy System Ethicon, Inc. The GYNECARE THERMACHOICE¿ III Uterine Balloon Therapy (UBT) System is a thermal balloon ablation device intended to ablate the endometrial lining of the uterus in pre-menopausal women with menorrhagia (excessive uterine bleeding) due to benign causes for whom childbearing is complete.. Recalled by Ethicon, Inc.. Units affected: 96,124 units.
Why was this product recalled?
Stability data does not substantiate the labeled two-year shelf life of affected product.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 13, 2016. Severity: Moderate. Recall number: Z-0602-2016.